ID: ALA590040

Max Phase: Preclinical

Molecular Formula: C13H12N2O3S2

Molecular Weight: 308.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=C2\SC(=S)N(NC(C)=O)C2=O)cc1

Standard InChI:  InChI=1S/C13H12N2O3S2/c1-8(16)14-15-12(17)11(20-13(15)19)7-9-3-5-10(18-2)6-4-9/h3-7H,1-2H3,(H,14,16)/b11-7-

Standard InChI Key:  HFMUELHXGBWHTI-XFFZJAGNSA-N

Associated Targets(non-human)

LL-diaminopimelate aminotransferase, chloroplastic 120 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 308.38Molecular Weight (Monoisotopic): 308.0289AlogP: 1.95#Rotatable Bonds: 3
Polar Surface Area: 58.64Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.71CX Basic pKa: CX LogP: 1.99CX LogD: 1.99
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.68Np Likeness Score: -1.56

References

1. Fan C, Clay MD, Deyholos MK, Vederas JC..  (2010)  Exploration of inhibitors for diaminopimelate aminotransferase.,  18  (6): [PMID:20185317] [10.1016/j.bmc.2010.02.001]

Source